Nina Wobst
6Patents
2h-index
23Co-inventors
43Inventor score
Filing activity: Mar 1, 2011 → Mar 1, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8481030B2 | Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI) | Chemistry; Metallurgy | 7 | Active |
| US10597674B2 | HPPD variants and methods of use | Chemistry; Metallurgy | 2 | Active |
| US9309324B2 | Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI) | Chemistry; Metallurgy | 2 | Active |
| US11371056B2 | HPPD variants and methods of use | Chemistry; Metallurgy | 0 | Active |
| US11180770B2 | HPPD variants and methods of use | Chemistry; Metallurgy | 0 | Active |
| USRE47150E1 | Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI) | General | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.